Abstract
Amiodarone is an antiarrhythmic agent among the most powerful and the most frequently used for the control of recurrent ventricular tachycardia and the secondary prevention of recurrent atrial fibrillation. Its use is not without risk. Although highly effective, it may induce various, sometimes severe, side effects, particularly at the thyroid level. In patients receiving amiodarone, one can encounter biological changes without clinical repercussion. Some may present a true thyroid disease, either hyper- or hypothyroidism. In this literature review, we will see how to prevent, diagnose, and treat these complications, if required.
Author supplied keywords
Cite
CITATION STYLE
Brescia, L., Benoit, A., Betea, D., Delvenne, P., Hamoir, E., & Beckers, A. (2014). Amiodarone and the thyroid. Revue Medicale de Liege, 69(10), 549–554. https://doi.org/10.4158/ep.4.1.48
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.